203 related articles for article (PubMed ID: 22290024)
1. Free asymmetric dimethylarginine (ADMA) is low in children and adolescents with classical phenylketonuria (PKU).
Huemer M; Simma B; Mayr D; Möslinger D; Mühl A; Schmid I; Ulmer H; Bodamer OA
J Inherit Metab Dis; 2012 Sep; 35(5):817-21. PubMed ID: 22290024
[TBL] [Abstract][Full Text] [Related]
2. Asymmetric dimethylarginine as a potential biomarker for management and follow-up of phenylketonuria.
Andrade F; Villate O; Couce ML; Bueno MA; Alcalde C; de Las Heras J; Ceberio L; Núñez-Marcos S; Nambo PS; Aldámiz-Echevarría L
Eur J Pediatr; 2019 Jun; 178(6):903-911. PubMed ID: 30941500
[TBL] [Abstract][Full Text] [Related]
3. Asymmetric dimethylarginine in children with homocystinuria or phenylketonuria.
Kanzelmeyer N; Tsikas D; Chobanyan-Jürgens K; Beckmann B; Vaske B; Illsinger S; Das AM; Lücke T
Amino Acids; 2012 May; 42(5):1765-72. PubMed ID: 21472412
[TBL] [Abstract][Full Text] [Related]
4. Influence of phenylketonuria's diet on dimethylated arginines and methylation cycle.
Andrade F; López-Suárez O; Llarena M; Couce ML; Aldámiz-Echevarría L
Medicine (Baltimore); 2017 Jul; 96(27):e7392. PubMed ID: 28682891
[TBL] [Abstract][Full Text] [Related]
5. Diet in children with phenylketonuria and risk of cardiovascular disease: A narrative overview.
Verduci E; Banderali G; Moretti F; Lassandro C; Cefalo G; Radaelli G; Salvatici E; Giovannini M
Nutr Metab Cardiovasc Dis; 2016 Mar; 26(3):171-7. PubMed ID: 26708644
[TBL] [Abstract][Full Text] [Related]
6. Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients.
Kumagai H; Sakurai M; Takita T; Maruyama Y; Uno S; Ikegaya N; Kato A; Hishida A
Am J Kidney Dis; 2006 Nov; 48(5):797-805. PubMed ID: 17059999
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.
Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA
Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528
[TBL] [Abstract][Full Text] [Related]
8. Optimal serum phenylalanine for adult patients with phenylketonuria.
Okano Y; Nagasaka H
Mol Genet Metab; 2013 Dec; 110(4):424-30. PubMed ID: 24094552
[TBL] [Abstract][Full Text] [Related]
9. Unexpectedly low asymmetric dimethylarginine (ADMA) and homocysteine levels in patients with phenylketonuria(PKU).
Ozcan O; Ipcioglu OM; Gultepe M
J Inherit Metab Dis; 2012 Nov; 35(6):1153. PubMed ID: 22729818
[No Abstract] [Full Text] [Related]
10. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
[TBL] [Abstract][Full Text] [Related]
11. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
Krzyzanowska K; Mittermayer F; Krugluger W; Schnack C; Hofer M; Wolzt M; Schernthaner G
Atherosclerosis; 2006 Nov; 189(1):236-40. PubMed ID: 16414052
[TBL] [Abstract][Full Text] [Related]
12. Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance.
Teerlink T
Clin Chem Lab Med; 2005; 43(10):1130-8. PubMed ID: 16197310
[TBL] [Abstract][Full Text] [Related]
13. ADMA and hyperhomocysteinemia.
Dayal S; Lentz SR
Vasc Med; 2005 Jul; 10 Suppl 1():S27-33. PubMed ID: 16444866
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension.
Wang D; Strandgaard S; Iversen J; Wilcox CS
Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R195-200. PubMed ID: 18685064
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
Suda O; Tsutsui M; Morishita T; Tasaki H; Ueno S; Nakata S; Tsujimoto T; Toyohira Y; Hayashida Y; Sasaguri Y; Ueta Y; Nakashima Y; Yanagihara N
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1682-8. PubMed ID: 15217805
[TBL] [Abstract][Full Text] [Related]
16. Association of asymmetric dimethylarginine and endothelial dysfunction.
Böger RH
Clin Chem Lab Med; 2003 Nov; 41(11):1467-72. PubMed ID: 14656027
[TBL] [Abstract][Full Text] [Related]
17. Serum asymmetric dimethylarginine and nitric oxide levels in Turkish patients with acute ischemic stroke.
Ercan M; Mungan S; Güzel I; Celik HT; Bal C; Abusoglu S; Akbulut D; Oguz EF; Yilmaz FM
Adv Clin Exp Med; 2019 May; 28(5):693-698. PubMed ID: 30170483
[TBL] [Abstract][Full Text] [Related]
18. The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.
Ozcan O; Cakir E; Yaman H; Akgul EO; Erturk K; Beyhan Z; Bilgi C; Erbil MK
Clin Endocrinol (Oxf); 2005 Aug; 63(2):203-6. PubMed ID: 16060915
[TBL] [Abstract][Full Text] [Related]
19. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease.
Selley ML
Neurobiol Aging; 2003 Nov; 24(7):903-7. PubMed ID: 12928048
[TBL] [Abstract][Full Text] [Related]
20. Low levels of asymmetric dimethylarginine in children with diabetes mellitus type I compared with healthy children.
Huemer M; Simma B; Mayr D; Mühl A; Rami B; Schober E; Ulmer H; Zanier U; Bodamer OA
J Pediatr; 2011 Apr; 158(4):602-606.e1. PubMed ID: 21074173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
